Nemours/A. I. DuPont Hospital for Children, 1600 Rockland Rd, Wilmington, DE, USA.
Department of Applied Economics and Statistics, University of Delaware, Newark, DE, USA.
J Public Health (Oxf). 2019 Jun 1;41(2):329-337. doi: 10.1093/pubmed/fdy104.
We performed the first epidemiologic investigation to examine association of demographics and clinical characteristics at diagnosis, as well as health care expense coverage, with survival of US children with aplastic anemia (AA).
We obtained electronic medical record data of 1140 children aged 0-19 years diagnosed with AA followed at a pediatric health system between 2004 and 2014. Kaplan-Meier curve and Cox proportional hazards regressions were used.
Self-pay patients had a mortality risk five times higher than that of those insured by publicly funded insurance (hazards ratio, 95% CI: 6.0, 3.7-9.8). Other features associated with higher mortality risk include pancytopenia (hazards ratio, referent: 4.2, constitutional AA); underweight (2.0, normal-weight); platelet count <50 × 109/l (1.3, ≥50 × 109/l); male sex (1.3, female); and ages at diagnosis 6-11, 11-16 and 16-19 years (1.6, 1.9, 2.3, 1-3 years), respectively.
Self-pay was the strongest prognostic factor for pediatric AA mortality. Older age, pancytopenia, underweight, male sex and lower platelet count were also associated with increased risk of mortality. These findings may be useful for providers, researchers and policymakers to ensure effective health care delivery to this population and to motivate future etiologic research and establishment of a surveillance registry.
我们进行了首次流行病学调查,以研究人口统计学和诊断时的临床特征,以及医疗保险覆盖范围与美国再生障碍性贫血(AA)患儿生存的关系。
我们获得了 2004 年至 2014 年期间在一家儿科医疗系统就诊的 1140 名 0-19 岁确诊为 AA 的儿童的电子病历数据。使用 Kaplan-Meier 曲线和 Cox 比例风险回归进行分析。
自付费患者的死亡率是由公共资助保险承保的患者的五倍(风险比,95%置信区间:6.0,3.7-9.8)。其他与更高死亡率风险相关的特征包括全血细胞减少症(风险比,参考值:4.2,特发性 AA);体重不足(2.0,正常体重);血小板计数<50×109/L(1.3,≥50×109/L);男性(1.3,女性);诊断时年龄为 6-11、11-16 和 16-19 岁(1.6、1.9、2.3,1-3 岁)。
自付费是儿科 AA 死亡率的最强预后因素。年龄较大、全血细胞减少症、体重不足、男性和较低的血小板计数也与死亡率增加相关。这些发现可能对提供者、研究人员和政策制定者有用,以确保为该人群提供有效的医疗服务,并激励未来的病因学研究和建立监测登记处。